Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06855732 · ClinicalTrials.gov registry record · NA
Pain Self-Management and Treatment Engagement for Patients Taking Opioids
A NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 16
- Study locations
NCT06855732: Recruiting NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of Pittsburgh.
NCT06855732 is a NA study of Chronic Pain and Opioid Use Disorder that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 204 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower). The trial reports 16 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06855732, a NA study of Chronic Pain and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 16
- Study locations
Study Summary
The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participants engage in treatment for opioid use? Researchers will compare PSM to standard care to see if PSM is effective in managing chronic pain and engagement in treatment. Participants will: * Take part in the PSM program or receive standard care for 12 weeks after enrolling in the study * Complete surveys every 3 months for 9 months (total of 4 visits) Participants will receive compensation for participating in the study. There are risks associated with participating in the study, including breach of confidentiality and psychological distress caused by discussing difficult topics.
Primary Outcome
The PROMIS Pain Interference - Short Form 4a is a validated, self-report 4-item tool assessing pain interference over the past 7 days. The PROMIS SF v1.0 - Pain Interference 4a consists of 4 questions and uses a 5-point scale, ranging from 1 (not at all) to 5 (very much). The total raw score equals the sum the values of the response to each question. The raw score is converted to a T-score. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (S
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Pain Self-Management
Study Locations (16)
Pennsylvania
- Renaissance Family Practice - Hampton Office - Allison Park
- Renaissance Family Practice - RIDC Office - Blawnox
- Renaissance Family Practice - Glenshaw Office - Glenshaw
- Renaissance Family Practice - Millvale Office - Pittsburgh
- Community Medicine, Inc. - Pittsburgh
- UPMC General Internal Medicine-Montefiore - Pittsburgh
- Renaissance Family Practice - Aspinwall Office - Pittsburgh
- UPMC General Internal Medicine-Shadyside (Shea Medical Center) - Pittsburgh
- Renaissance Family Practice - Harmarville Office - Pittsburgh
- UPMC General Internal Medicine-Turtle Creek - Turtle Creek
- Renaissance Family Practice - Penn Hills Office - Verona
- UPMC General Internal Medicine-South - West Mifflin
West Virginia
- St. Joseph's Rural Health Clinic (WVU Medicine) - Buckhannon
- Harpers Ferry Family Medicine (WVU Medicine) - Harpers Ferry
- WVU Medicine University Town Centre - Morgantown
- WVU Medicine Primary Care - Shepherdstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2024-11-25 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06855732 shows while recruiting
NCT06855732 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06855732 lists 16 locations in 2 states (Pennsylvania, West Virginia).
Frequently Asked Questions
What is clinical trial NCT06855732 about?
NCT06855732 is a clinical study titled "Pain Self-Management and Treatment Engagement for Patients Taking Opioids". The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participan...
What is the current status of trial NCT06855732?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2024-11-25. Estimated completion is 2026-12-31.
What conditions does trial NCT06855732 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Opioid Misuse and Addiction.
What interventions are being tested in trial NCT06855732?
The interventions under investigation include: Usual Care (BEHAVIORAL), Pain Self-Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06855732?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06855732 being conducted?
This trial has 16 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06855732's enrollment target sits among peer trials
204 80th of 301 higher than 221 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI